Arild Mæland
Position:
Phone:
Email:
 

Author network for Arild Mæland by COREMINE medical


Publications 2016

Midgard H, Bjøro B, Mæland A, Konopski Z, Kileng H, Damås JK, Paulsen J, Heggelund L, Sandvei PK, Ringstad JO, Karlsen LN, Stene-Johansen K, Pettersson JH, Dorenberg DH, Dalgard O (2016)
Hepatitis C reinfection after sustained virological response
J Hepatol, 64 (5), 1020-1026
PubMed 26780289

Publications 2014

Maeland A (2014)
Antiretroviral treatment initiation
Lancet Infect Dis, 14 (12), 1175
PubMed 25455976

Publications 2013

Ushakova A, Pettersen FO, Mæland A, Lindqvist BH, Kvale D (2013)
Bayesian estimation of HIV-1 dynamics in vivo
Math Med Biol, 32 (1), 38-55
PubMed 24078026

Publications 2010

Jenum PA, Flesland Ø, Blystad H, Vik IS, Hervig T, Maeland A, Saeter G (2010)
[Syphilis and blood transfusion]
Tidsskr Nor Laegeforen, 130 (8), 839-41
PubMed 20418930

Publications 2009

Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
J Clin Microbiol, 47 (7), 2170-4
PubMed 19420166

Publications 2007

Jensenius M, Maeland A, Brubakk O (2007)
Extensive hookworm-related cutaneous larva migrans in Norwegian travellers to the tropics
Travel Med Infect Dis, 6 (1-2), 45-7
PubMed 18342274

Publications 2006

Bruun JN, Skeie L, Maeland A, Dudman SG, Sannes M, Ormaasen V (2006)
[HIV/AIDS--from lethal syndrome to chronic disease]
Tidsskr Nor Laegeforen, 126 (23), 3121-4
PubMed 17160119

Skeie L, Maeland A (2006)
Can efavirenz be taken in the morning?
Scand J Infect Dis, 38 (11-12), 1089-91
PubMed 17148083

Publications 2002

Bjøro K, Bell H, Hellum KB, Skaug K, Raknerud N, Sandvei P, Døskeland B, Maeland A, Lund-Tønnesen S, Myrvang B (2002)
Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study
Scand J Gastroenterol, 37 (2), 226-32
PubMed 11843062

Bruun JN, Maeland A (2002)
[Mother-to-child transmission of HIV]
Tidsskr Nor Laegeforen, 122 (11), 1143; author reply 1143
PubMed 12043061

Publications 2001

Ormaasen V, Maeland A (2001)
[Tuberculosis among HIV-infected persons in Norway]
Tidsskr Nor Laegeforen, 121 (29), 3425-30
PubMed 11826791

Publications 1999

Bell H, Hellum K, Harthug S, Myrvang B, Ritland S, Maeland A, von der Lippe B, Bjøro K, Skaug K, Gutigard BG, Raknerud N, Simmonds P (1999)
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group
Scand J Gastroenterol, 34 (2), 194-8
PubMed 10192200

Publications 1998

Brantsaeter AB, Hoel T, Kristianslund TI, Maeland A (1998)
[Tularemia after tick bite in Vestfold]
Tidsskr Nor Laegeforen, 118 (8), 1191-3
PubMed 9567695

Jarvis LM, Bell H, Simmonds P, Hawkins A, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K (1998)
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group
Scand J Gastroenterol, 33 (2), 195-200
PubMed 9517532

Publications 1997

Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Gutigard BG, Skjaerven R, Prescott LE, Simmonds P (1997)
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group
Scand J Infect Dis, 29 (1), 17-22
PubMed 9112292

Jensenius M, Maeland A, Kvale D, Farstad IN, Vene S, Bruu AL (1997)
[Q-fever imported into Norway]
Tidsskr Nor Laegeforen, 117 (27), 3937-40
PubMed 9441420

Jensenius M, Maeland A, Vene S (1997)
[Endemic typhus imported to Norway]
Tidsskr Nor Laegeforen, 117 (17), 2447-9
PubMed 9265302

Maeland A (1997)
[Screening of pregnant women for toxoplasma infection]
Tidsskr Nor Laegeforen, 117 (8), 1184-5
PubMed 9148496

Nordøy I, Krarup HB, Bell H, Christensen PB, Elgjo K, von der Lippe B, De Muckadell OS, Maeland A, Ring-Larsen H, Samdal HH, Simmonds P, Skaug K, Tage-Jensen U, Schrumpf E (1997)
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study
Scand J Gastroenterol, 32 (12), 1256-60
PubMed 9438325

Publications 1996

Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Prescott L, Simmonds P (1996)
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group
Scand J Infect Dis, 28 (4), 357-9
PubMed 8893398

Schrumpf E, Bjøro K, Bell H, Harthug S, Hellum KB, Myrvang B, Maeland A, Ritland S (1996)
[Treatment of hepatitis C]
Tidsskr Nor Laegeforen, 116 (15), 1792-4
PubMed 8693463

Publications 1995

BJORO K, KRARUP H, BELL H, CHRISTOPHERSEN P, EVENSEN S, FROLAND SS, LAURSEN A, VANDERLIPPE B, MAELAND A, RANEK L, RINGLARSEN H, SCHOU G, SCHRUMPF E, TYGSTRUP N (1995)
2 DOSE REGIMENS OF RECOMBINANT INTERFERON-ALPHA-2B IN CHRONIC HEPATITIS-C VIRUS-INFECTION - BIOCHEMISTRY, HEPATITIS-C VIRUS RNA, AND LIVER HISTOLOGY AS RESPONSE INDICES
Scand. J. Gastroenterol., 30 (11), 1119-1124

Bjøro K, Krarup H, Bell H, Christophersen P, Evensen S, Frøland SS, Laursen A, B vd Lippe B, Maeland A, Ranek L (1995)
Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices
Scand J Gastroenterol, 30 (11), 1119-24
PubMed 8578174

Publications 1993

Sandven P, Bjørneklett A, Maeland A (1993)
Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group
Antimicrob Agents Chemother, 37 (11), 2443-8
PubMed 8285631

Publications 1992

LARSEN J, SKAUG K, MAELAND A (1992)
2ND-GENERATION ANTI-HCV TESTS PREDICT INFECTIVITY
Vox Sang., 63 (1), 39-42

Larsen J, Skaug K, Maeland A (1992)
Second-generation anti-HCV tests predict infectivity
Vox Sang, 63 (1), 39-42
PubMed 1384236

NORRBY SR, GOTZSCHE PC, MELANDER H, ANDERSEN P, LAHDEVIRTA J, GUDMUNDSSON S, BRUUN JN, BERGLUND O, SKINHOJ P, GERSTOFT J, THYBO S, GIEMSING P, SOEBERG B, ISAGER H, MOLLER A, KROON S, MAELAND A, DOBLOUG JH, FROLAND S, SCHREINER A, HELLUM KB, LINDBACK S, JACOBSSON B, PEHRSON PO, SKOLDENBERG B et al. (1992)
DOUBLE-BLIND DOSE-RESPONSE STUDY OF ZIDOVUDINE IN AIDS AND ADVANCED HIV-INFECTION
Br. Med. J., 304 (6818), 13-17

Publications 1991

Larsen J, Hetland G, Skaug K, Maeland A (1991)
[Viral hepatitis and blood transfusion]
Tidsskr Nor Laegeforen, 111 (7), 825-8
PubMed 1850559

Larsen J, Skaug K, Maeland A, Hetland G, Stoervold G (1991)
Infective, chronic carriers of hepatitis C virus among blood donors with no history of clinical hepatitis
Transfus Med, 1 (1), 13-6
PubMed 9259821

Maeland A (1991)
[Cutaneous leishmaniasis]
Tidsskr Nor Laegeforen, 111 (29), 3512-4
PubMed 1796438

Publications 1989

MAELAND A, SKAUG K, STORVOLD G, KITTELSEN P (1989)
REACTIVATION OF HEPATITIS-B
Lancet, 1 (8646), 1083

Publications 1988

Maeland A (1988)
[Acute HIV disease]
Tidsskr Nor Laegeforen, 108 (22), 1619-20, 1654
PubMed 3413748